openPR Logo
Press release

3D Printed Drugs Market Growth Opportunity Analysis and Revenue by Top Key Players Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd.

10-22-2018 11:54 AM CET | Health & Medicine

Press release from: Allied Market Research

3D Printed Drugs Market

3D Printed Drugs Market

3D Printed Drugs Market by Forecast Scenario Analysis: Spritam is the only 3D printed drug available in the market since 2016 to treat epilepsy. The potential market for other 3D printed drugs (moderate growth scenario) is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030. U.S. market holds the highest market share in 2020.

3D printed drugs are medications created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have porous structures that can disintegrate rapidly inside the mouth itself. Aprecia Pharmaceuticals Companys SPRITAM levetiracetam is the first 3D printed drug, which has been approved by the U.S. Food and Drug Administration (FDA) in August 2015.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4508

The key players profiled in this report include
• Aprecia Pharmaceuticals
• GlaxoSmithKline Plc.
• Hewlett Packard Caribe
• BV
• LLC
• 3D Printer Drug Machine
• FabRx Ltd.

Constant technological developments in 3D printing technique, rise in incidence of epilepsy cases, and increase in awareness about the 3D printing technology in the developing countries drive the growth of the market. However, lack of government regulations related to these drugs and adverse effects of 3D printed drugs are expected to limit the market growth.
The global 3D printed drugs market is analyzed based on forecast scenario such as low growth scenario, moderate growth scenario, and rapid growth scenario.

According to low growth scenario, the U.S. is anticipated to account for the highest market share in 2020, and rest of North America market is expected to grow at the highest rate, registering the CAGR of 5.1% by 2030.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4508

Europe is estimated to account for four-sevenths share in 2020, and is expected to dominate the market throughout the forecast period, due to presence of well-established healthcare systems and increase in prevalence of dysphagia. In addition, increase in adoption of 3D printed drugs is anticipated to provide new growth opportunities for the key players in the European market. However, Asia-Pacific is projected to grow at the highest growth rate during the analysis period, owing to increase in healthcare expenditure, rise in awareness related to 3D printing technique, presence of large patient pool, and developments in healthcare infrastructure.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4508

The organizations engaged in the research of 3D printed drugs included in this report are UCL School of Pharmacy, University of Glasgow, University College London, The University of Nottingham, and National University of Singapore.

Key Findings of 3D Printed Drugs Market:
• In North America, the U.S. is anticipated to dominate the market in 2020, whereas rest of North America is projected to grow at the highest CAGR during the forecast period.
• Germany was the major shareholder in the European 3D printed drugs market in 2016.
• Asia-Pacific is expected to register the highest growth rate in future.
• Australia is expected to grow at the highest CAGR in the Asia-Pacific 3D printed drugs market.

Access Full Summery @ https://www.alliedmarketresearch.com/3d-printed-drugs-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 3D Printed Drugs Market Growth Opportunity Analysis and Revenue by Top Key Players Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd. here

News-ID: 1317963 • Views:

More Releases from Allied Market Research

Child Resistant Packaging Market to Grow at a CAGR of 6.5% and Expected to Reach $44 billion by 2031
Child Resistant Packaging Market to Grow at a CAGR of 6.5% and Expected to Reach …
Child Resistant Packaging Market by Material (Plastic, Metal, Glass, Paper and paperboard), by End-user industry (Food and beverage, Pharmaceutical, Personal and home care, Others), by Product type (Caps and closures, Blisters, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global child ressistant packaging industry was estimated at $23.2 billion in 2021, and is anticipated to hit $44 billion by 2031, registering a CAGR of 6.5%
Septic Tanks Market Continues to Grow, with $8 billion Valuation and 5.2% CAGR Forecasted 2021-2031
Septic Tanks Market Continues to Grow, with $8 billion Valuation and 5.2% CAGR F …
The global septic tanks market size was valued at $4.8 billion in 2021, and is projected to reach $8 billion by 2031, growing at a CAGR of 5.2% from 2022 to 2031. The High-Pressure Grinding Roller Market report defines and outlines the products, applications, and specifications to the reader. The study lists the leading companies operating in the Market and highlights the key change processes that companies have adopted to
Hazmat Packaging Market Reach $17.2 billion, Globally, at 5.4% CAGR dominated by Asia Pacific during 2021-2031
Hazmat Packaging Market Reach $17.2 billion, Globally, at 5.4% CAGR dominated by …
Rise in various end-user industries such as chemicals, pharmaceuticals, and others are creating the demand for the drum, intermediate bulk containers for transportation of hazardous goods driving the growth of the global hazmat packaging market. By product type, the Drums segment held the highest share in 2021. By region, Asia-Pacific would showcase the fastest CAGR by 2031. The global hazmat packaging market was estimated at $10.2 billion in 2021 and is
Green Steel Market Continues to Grow, with $364.5 billion Valuation and 113.6% CAGR Forecasted 2023-2032
Green Steel Market Continues to Grow, with $364.5 billion Valuation and 113.6% C …
The growth of the green steel market is driven by the growth in awareness of environmentally friendly steel manufacturing in various sectors such as construction, automotive, and manufacturing and rising investments in greenfield ventures, collaborations, and strategic alliances to increase the production of low carbon emission green steel Green Steel Market by Type (Electric Arc Furnace (EAF), Molten Oxide Electrolysis (MOE)), and End-user (Construction, Automotive, Electronics, and Others): Global Opportunity Analysis

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug